Ortho Regenerative Technologies (ORTH.C) got some bad news today in the form of a clinical hold letter from the FDA related to their investigational new drug (IND) application fo…
ORTH.C
“2021 will be transformational for the company as we advance the clinical development of our lead product,” added LeDuc….
Soft tissue injuries such as sprains, strains and tendonitis result in nearly 70 million physician office visits a year in the U.S. alone, creating an annual USD$54 billion economic…